Yissum - Research Development Company of the Hebrew University

Early Evaluation of Embryo Developmental Competence for IVF Infertility Treatments

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Early Evaluation of Embryo Developmental Competence for IVF Infertility Treatments
Project ID : 7-2015-3178

Description of the technology

Category

Computer Science and Engineering, Life Science & Biotechnology

Keywords

In vitro fertilization (IVF), embryo development competence, machine learning, neural network algorithms

Current development stage

TRL4 Technology validated in lab

Our Innovation

  • The researchers developed a unique technology to identify an in-vitro grown embryo with highest chances of healthy development during future uterus implantation. The technology has both in human and veterinary IVF fertility applications
  • The researchers developed a simple method and a dedicated device to select the most likely embryo from a plurality of possible candidates. The technology involves determination of optical parameters
  • The proof of concept was successful for cattle embryos

Opportunity

Today, 4% of newborn babies are conceived via IVF procedures and this market is expanding rapidly worldwide. This diagnostic technology will be integrated into the methodological practice of IVF clinics and centers

Project manager

Mel Larrosa
VP Business Development Healthcare

Project researchers

Amnon Buxboim
HUJI, School of Computer Science and Engineering
Bio-Engineering

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Diagnostic
  • Therapeutic
  • Other Medical/Health Related
  • Agro and Marine biotech
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Life Science & Biotechnology
  • diagnostics

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.